Zsuzsanna Csorgo-Bata

Szeged, CS, Hungary

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 67 publications

Correction: Efficacy of Intravenous Immunoglobulin for Systemic Manifestations of Dermatomyositis Beyond Muscular and Cutaneous: Sub‑analysis of the ProDERM Study.

Correction: Efficacy of Intravenous Immunoglobulin for Systemic Manifestations of Dermatomyositis Beyond Muscular and Cutaneous: Sub‑analysis of the ProDERM Study.

Journal: Rheumatology and therapy
Published: August 13, 2026

Clinical Features That May Refine Malignancy Risk Stratification in Adult Dermatomyositis: A Retrospective Case-Control Study in the IMACS Era.

Clinical Features That May Refine Malignancy Risk Stratification in Adult Dermatomyositis: A Retrospective Case-Control Study in the IMACS Era.

Journal: International journal of dermatology
Published: March 16, 2026

Proposition for a New Classification of Hypersensitivity Reactions - an Expanded Nomenclature.

Proposition for a New Classification of Hypersensitivity Reactions - an Expanded Nomenclature.

Journal: Clinical reviews in allergy & immunology
Published: November 08, 2025

Safety profile of efgartigimod from global clinical trials across multiple immunoglobulin G-mediated autoimmune diseases.

Safety profile of efgartigimod from global clinical trials across multiple immunoglobulin G-mediated autoimmune diseases.

Journal: Expert review of clinical immunology
Published: April 29, 2025

Efficacy of Intravenous Immunoglobulin for Systemic Manifestations of Dermatomyositis Beyond Muscular and Cutaneous: Sub-analysis of the ProDERM Study.

Efficacy of Intravenous Immunoglobulin for Systemic Manifestations of Dermatomyositis Beyond Muscular and Cutaneous: Sub-analysis of the ProDERM Study.

Journal: Rheumatology and therapy
Published: March 21, 2025

Beneficial Therapeutic Effect of Endothelin-Receptor Antagonist in Generalized Morphea: A Report of Two Cases.

Beneficial Therapeutic Effect of Endothelin-Receptor Antagonist in Generalized Morphea: A Report of Two Cases.

Journal: International journal of dermatology
Published: January 15, 2025

The Complex Nomenclature of Allergic Diseases and Hypersensitivity Reactions: An Addendum to the EAACI Position Paper.

The Complex Nomenclature of Allergic Diseases and Hypersensitivity Reactions: An Addendum to the EAACI Position Paper.

Journal: Allergy
Published: October 25, 2024

Predictors of response to intravenous immunoglobulin in patients with dermatomyositis: the ProDERM study.

Predictors of response to intravenous immunoglobulin in patients with dermatomyositis: the ProDERM study.

Journal: Rheumatology (Oxford, England)
Published: October 03, 2024

The Expression of Cytokines and Chemokines Potentially Distinguishes Mild and Severe Psoriatic Non-Lesional and Resolved Skin from Healthy Skin and Indicates Different Stages of Inflammation.

The Expression of Cytokines and Chemokines Potentially Distinguishes Mild and Severe Psoriatic Non-Lesional and Resolved Skin from Healthy Skin and Indicates Different Stages of Inflammation.

Journal: International journal of molecular sciences
Published: September 22, 2024

Unraveling Transcriptome Profile, Epigenetic Dynamics, and Morphological Changes in Psoriasis-like Keratinocytes: "Insights into Similarity with Psoriatic Lesional Epidermis".

Unraveling Transcriptome Profile, Epigenetic Dynamics, and Morphological Changes in Psoriasis-like Keratinocytes: "Insights into Similarity with Psoriatic Lesional Epidermis".

Journal: Cells
Published: October 01, 2023

Abnormal basement membrane results in increased keratinocyte-derived periostin expression in psoriasis similar to wound healing.

Abnormal basement membrane results in increased keratinocyte-derived periostin expression in psoriasis similar to wound healing.

Journal: Scientific reports
Published: July 21, 2023

Safety and tolerability of intravenous immunoglobulin in patients with active dermatomyositis: results from the randomised, placebo-controlled ProDERM study.

Safety and tolerability of intravenous immunoglobulin in patients with active dermatomyositis: results from the randomised, placebo-controlled ProDERM study.

Journal: Arthritis research & therapy
Published: June 08, 2023
Showing 1-12 of 67

Last Updated: 09/26/2026